Peter Devilee

Professor in Tumor Genetics, section leader

Leiden University Medical Center

Netherlands

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Turkish students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Biostatistics

70%

Cell Biology

50%

Medical Science

70%

Genomic

60%

Cancer Biology

50%

Gwas

20%

Cancer Genetics

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

Breast Cancer Risk After Diagnostic Gene Sequencing

Open Date: 2015-09-01

Close Date: 2020-08-01

Articles10

Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases

Article Link

Year:

2023

LncRNA LITATS1 suppresses TGF‐β‐induced EMT and cancer cell plasticity by potentiating TβRI degradation

Article Link

Year:

2023

SDHBvariant type impacts phenotype and malignancy in pheochromocytoma-paraganglioma

Article Link

Year:

2023

Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry

Article Link

Year:

2022

Hypothesis: Why Different Types of SDH Gene Variants Cause Divergent Tumor Phenotypes

Article Link

Year:

2022

Assessment of psychosocial difficulties by genetic clinicians and distress in women at high risk of breast cancer: a prospective study

Article Link

Year:

2022

RAD51D Aberrant Splicing in Breast Cancer: Identification of Splicing Regulatory Elements and Minigene-Based Evaluation of 53 DNA Variants

Article Link

Year:

2021

Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I)

Article Link

Year:

2021

Comprehensive Functional Characterization and Clinical Interpretation of 20 Splice-Site Variants of the RAD51C Gene

Article Link

Year:

2020

Clustering of known low and moderate risk alleles rather than a novel recessive high‐risk gene in non‐BRCA1/2 sib trios affected with breast cancer

Article Link

Year:

2020

Collaborators19

Elena Bueno Martínez

Profesora Ayudante Doctora

Universidad de Valladolid

SPAIN

Maaike P.G. Vreeswijk

Associate Professor

Leiden University Medical Center

NETHERLANDS

William Newman

The University of Manchester

UNITED KINGDOM

Gary Bader

Professor

University of Toronto

CANADA

Dominique Stoppa-Lyonnet

Institut Curie

FRANCE

Emmanouil Saloustros

Associate Professor

Panepistemio Thessalias Tmema Iatrikes

GREECE

John W. M. Martens

NETHERLANDS

Eladio Andrés Velasco-Sampedro

SPAIN

Anna Gonzalez-Neira

Head

Centro Nacional de Investigaciones Oncológicas

SPAIN

Stig E. Bojesen

Copenhagen University Hospital

DENMARK

Bing-Jian Feng

Research Associate Professor

University of Utah

UNITED STATES

Jean-Sébastien Paquette

Laval University

CANADA

Peter Hillemanns

Prof. Dr.

Medizinische Hochschule Hannover

GERMANY

Sabine Behrens

Deutsches Krebsforschungszentrum

GERMANY

Corinna Ernst

University of Cologne

GERMANY

mikael eriksson

Karolinska Institutet

SWEDEN

Felix Grassmann

Professor of Epidemiology

Health and Medical University

GERMANY

Natalia Bogdanova

Head of Research Unit

Hannover Medical School

GERMANY

Philippe Després

Institut universitaire de cardiologie et de pneumologie de Québec

CANADA

How do Turkish students reach out?

Meet Kite AI

Peter Devilee

Professor in Tumor Genetics, section leader

How do Turkish students reach out?

Contact this professor

Research Interests

Ask ApplyKite AI

Recent Grants

Articles10

Spectrum and Frequency of Germline <i>FANCM</i> Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases

LncRNA LITATS1 suppresses TGF‐β‐induced EMT and cancer cell plasticity by potentiating TβRI degradation

SDHBvariant type impacts phenotype and malignancy in pheochromocytoma-paraganglioma

Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry

Hypothesis: Why Different Types of SDH Gene Variants Cause Divergent Tumor Phenotypes

Assessment of psychosocial difficulties by genetic clinicians and distress in women at high risk of breast cancer: a prospective study

<i>RAD51D</i> Aberrant Splicing in Breast Cancer: Identification of Splicing Regulatory Elements and Minigene-Based Evaluation of 53 DNA Variants

Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I)

Comprehensive Functional Characterization and Clinical Interpretation of 20 Splice-Site Variants of the <i>RAD51C</i> Gene

Clustering of known low and moderate risk alleles rather than a novel recessive high‐risk gene in non‐BRCA1/2 sib trios affected with breast cancer

Collaborators19

Elena Bueno Martínez

Maaike P.G. Vreeswijk

William Newman

Gary Bader

Dominique Stoppa-Lyonnet

Emmanouil Saloustros

John W. M. Martens

Eladio Andrés Velasco-Sampedro

Anna Gonzalez-Neira

Stig E. Bojesen

Bing-Jian Feng

Jean-Sébastien Paquette

Peter Hillemanns

Sabine Behrens

Corinna Ernst

mikael eriksson

Felix Grassmann

Natalia Bogdanova

Philippe Després

How do Turkish students reach out?